Skip to main content
. 2016 Nov 24;4(4):509–516. doi: 10.1002/mdc3.12454

Table 1.

Demographic and Clinical Features in Recent Onset Parkinson's Disease

Variable Total (N = 1738) Hoehn and Yahr Stage Heterogeneity (P Value) Trend (P Value)
1 (N = 855) 2 (N = 783) 3 + (N = 100)
Age (y) 67.6 (9.3) 66.1 (9.2) 68.7 (9.0) 71.8 (9.1) <0.001a <0.001a
Age at diagnosis (y) 66.3 (9.2) 64.9 (9.2) 67.3 (9.0) 70.3 (9.1) <0.001a <0.001a
Duration (y) 1.3 (0.9) 1.2 (0.9) 1.4 (0.9) 1.4 (1.0) <0.001b <0.001b
Male sex 1132 (65.1%) 539 (63.0%) 540 (69.0%) 53 (53.0%) 0.001c 0.88c
Drug naïve 168 (9.7%) 108 (12.6%) 56 (7.2%) 4 (4.1%) 0.007 d 0.001d
LEDD (mg) 294 (205) 264 (208) 320 (202) 353 (158) <0.001d <0.001d
MDS UPDRS 3 22.5 (12.1) 16.8 (8.8) 26.4 (11.3) 40.1 (13.7) <0.001d <0.001d
Motor Subtype
Tremor dominant 763 (46.9%) 414 (51.7%) 339 (46.2%) 10 (10.8%)
PIGD 652 (40.1%) 273 (34.1%) 306 (41.7%) 73 (78.5%) <0.001d <0.001d
Indeterminate 212 (13.0%) 114 (14.2%) 88 (12.0%) 10 (10.8%) 0.018d 0.45d
SCOPA‐AUT total 11.7 (7.0) 10.7 (6.2) 12.7 (7.6) 13.5 (6.9) <0.001d <0.001d

Eight cases with missing H&Y status are not shown; data are presented as mean and standard deviation or percentage.

LEDD, l‐dopa equivalent daily dose; MDS UPDRS 3, Movement Disorder Society Unified Parkinson's disease rating scale Part 3; PIGD, postural instability and gait difficulty; SCOPA‐AUT, scales for outcomes in Parkinson's disease—autonomic symptoms.

a

Adjusted for sex and disease duration.

b

Adjusted for sex and age.

c

Adjusted for age and disease duration.

d

Adjusted for sex, age, and disease duration.